PROTEUS MOLECULAR DESIGN has a total of 136 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United Kingdom, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are EISAI R AND D MAN CO LTD, KYOWA KIRIN CO LTD and CANBAS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 36 | |
#2 | Australia | 15 | |
#3 | WIPO (World Intellectual Property Organization) | 14 | |
#4 | EPO (European Patent Office) | 12 | |
#5 | Canada | 7 | |
#6 | South Africa | 7 | |
#7 | New Zealand | 6 | |
#8 | China | 5 | |
#9 | United States | 5 | |
#10 | Finland | 4 | |
#11 | Hungary | 4 | |
#12 | Norway | 4 | |
#13 | African Regional Industrial Property Organization | 2 | |
#14 | Israel | 2 | |
#15 | Mexico | 2 | |
#16 | African Intellectual Property Organization | 2 | |
#17 | Zimbabwe | 2 | |
#18 | Argentina | 1 | |
#19 | Brazil | 1 | |
#20 | Czechoslovakia | 1 | |
#21 | Denmark | 1 | |
#22 | Iceland | 1 | |
#23 | Portugal | 1 | |
#24 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Robson Barry | 51 |
#2 | Fishleigh Robert Vincent | 38 |
#3 | Alexander James | 20 |
#4 | Brewer James Macdonald | 17 |
#5 | Young Stephen Clinton | 11 |
#6 | Morgan Phillip John | 10 |
#7 | Fishleigh Robert V | 10 |
#8 | Quesnel Louis Bertrand | 9 |
#9 | Greaney Paul John | 8 |
#10 | Waszkowycz Bohdan | 7 |
Publication | Filing date | Title |
---|---|---|
GB9929553D0 | Compounds | |
GB9929552D0 | Compounds | |
GB9923710D0 | Chemical compounds | |
GB9918741D0 | Compounds | |
GB9913823D0 | Compounds | |
GB9913821D0 | Compounds | |
AU3620099A | Aminomethyl-benzoic ester derivatives as tryptase inhibitors | |
GB9822432D0 | Compounds | |
AU8875398A | 1-amino-7-isoquinoline derivatives as serine protease inhibitors | |
EP1486505A1 | Angiotensin derivatives | |
GB9808813D0 | Compounds | |
GB9808696D0 | Peptide derivatives | |
GB9803173D0 | Compounds | |
GB9727054D0 | Compounds | |
GB9718392D0 | Compounds | |
EP0818744A2 | Process for selecting candidate drug compounds | |
GB9713361D0 | Peptide derivatives | |
GB9616562D0 | Process | |
GB9614302D0 | Process | |
GB9515868D0 | Therapeutic method |